Location
United States, North America
Check Size
$100K - $5M
Investment Stage
Pre Seed
Seed
Series A
Series B
Focus Areas
AI
Health IT
Health & Hospital Services
Digital Health
BioTech
About Investor
Aymeric Sallin is the Founder and CEO of NanoDimension, a San Francisco Bay Area–based venture capital firm. He invests between $100K and $5.0M, focusing on pre-seed through Series B opportunities in biotech, AI, therapeutics, health IT, digital health, and healthcare services. He is a long-standing life sciences investor with a global portfolio in cutting-edge health and technology ventures.
Previous investments
Tarveda Therapeutics
30M |2017
21M |2015
21M |2013
3M |2012
Selecta Biosciences
15M |2010
15M |2009
Crocus Technology
44M |2013
11M |2010
16M |2008
Similar Investors
AL
Abdul Ly
United States, North America
$1M - $4M
Seed
,Series A
,PS
Paul Straub
United States, North America
$100K - $2M
Pre Seed
,Seed
,SA
Shaun Abrahamson
United States, North America
$250K - $1M
Pre Seed
,Seed
,RF
Riley Florsheim
United States, North America
$100K - $5M
Pre Seed
,Seed
,SB
Steve Brownlie
United States, North America
$250K - $1.4M
Pre Seed
,Seed
,DG
Danielle Graham
Canada, North America
$100K - $300K
Pre Seed
,Seed
,Is this You?
Is this you? Have any edits?
Fill out our update request form and we'll update ASAP

Grow with the Right Investors
This profile is just one example. Our AI matches you with the investors who best fit your stage, industry, and vision.
Start Matching For Free